EQS-News: Dermapharm Holding SE

/ Key word(s): Annual Results/Annual Report

Successful financial year 2024: Dermapharm increases revenue and exceeds EBITDA guidance

28.03.2025 / 07:30 CET/CEST

The issuer is solely responsible for the content of this announcement.Read More

You might also be interested in reading GlobalPass CEO on Compliance Industry Challenges and the Role of AI .